Crestline Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-238,615
Closed -$34.5M 339
2024
Q4
$34.5M Buy
238,615
+227,837
+2,114% +$35.3M 1.15% 9
2024
Q3
$1.75M Buy
+10,778
New +$1.72M 0.09% 206

Other funds holding JNJ

Crestline Management's JNJ Position: Q1 2025 in Review

Crestline Management sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 238,615 shares — an estimated $34.5M sold.

Crestline Management first reported a position in JNJ in Q3 2024 and held it in 2 quarters. The position peaked at $34.5M in Q4 2024. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Crestline Management reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 238,615 Johnson & Johnson shares in Q1 2025, an estimated $34.5M.
  • Crestline Management first reported a position in Johnson & Johnson in Q3 2024 and held it in 2 quarters.
  • Crestline Management's Johnson & Johnson position peaked at $34.5M in Q4 2024.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.